The HERO-study: Effects of Roflumilast in Patients With COPD (Chronic Obstructive Pulmonary Disease) (BY217/M2-121)

PHASE3CompletedINTERVENTIONAL
Enrollment

550

Participants

Timeline

Start Date

October 31, 2004

Conditions
Chronic Obstructive Pulmonary Disease, COPD
Interventions
DRUG

Roflumilast

Trial Locations (16)

Unknown

ALTANA Pharma, Cities in California

ALTANA Pharma, Cities in Colorado

ALTANA Pharma, Cities in Florida

ALTANA Pharma, Cities in Missouri

ALTANA Pharma, Cities in New Mexico

ALTANA Pharma, Cities in New York

ALTANA Pharma, Cities in Oregeon

ALTANA Pharma, Cities in South Carolina

ALTANA Pharma, Cities in Texas

ALTANA Pharma, Cities in Washington

ALTANA Pharma, Cities in Canada

ALTANA Pharma, Cities in France

ALTANA Pharma, Cities in Poland

ALTANA Pharma, Cities in South Africa

ALTANA Pharma, Cities in Spain

ALTANA Pharma, Cities in the United Kingdom

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY